Director & PDMR Shareholding (1437C)
02 Marzo 2011 - 8:02AM
UK Regulatory
TIDMCRW
RNS Number : 1437C
Craneware plc
02 March 2011
Craneware plc
("Craneware" or the "Company")
Director & PDMR Shareholding
2 March 2011 - Craneware plc (AIM: CRW.L; OTC: CRWRY), the
market leader in automated revenue integrity solutions for the US
healthcare market, has been informed that the two co-founders of
the business, Keith Neilson, Chief Executive Officer, and Gordon
Craig, CTO and recently appointed President of Craneware US
operations, each purchased yesterday 3,525 ordinary shares of 1p
each in the Company ("Ordinary Shares") at a price of 564.75 pence
per share.
Following these transactions, Mr. Neilson has a total holding in
the Company of 3,428,779 Ordinary Shares, which represents 12.95%
of the total issued share capital, and Mr. Craig has a total
holding in the Company of 3,153,151 Ordinary Shares, which
represents 11.91% of the total issued share capital.
Further to the Additional Listing announcement yesterday, it
should be noted that the denominator for these calculations
includes the 509,097 new ordinary shares which were allotted
yesterday to certain of the ClaimTrust, Inc. ("ClaimTrust")
vendors, as part of the initial consideration for the acquisition
of ClaimTrust. These shares are subject to a twelve month lock-in
once they are admitted on 3 March 2011.
For further information, please contact:
Craneware plc Peel Hunt Threadneedle Communications
+44 (0)131 550 +44 (0)20 7418
3160 8900 +44 (0)20 7653 9850
Keith Neilson, Dan Webster Caroline Evans-Jones
CEO
Craig Preston, Richard Kauffer Fiona Conroy
CFO
About Craneware
Founded in 1999, Craneware has headquarters in Edinburgh,
Scotland with offices in Atlanta, Arizona, Massachusetts and
Tennessee employing over 200 staff. Craneware is the leader in
automated revenue integrity solutions that improve financial
performance and mitigate risk for healthcare organisations.
Craneware's market-driven, SaaS solutions help hospitals and other
healthcare providers more effectively price, charge and code for
services and supplies associated with patient care. These optimise
reimbursement, increase operational efficiency and minimise
compliance risk. By partnering with Craneware, clients achieve the
visibility required to identify, address and prevent revenue
leakage. To learn more, visit craneware.com and
stoptheleakage.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSUAURRAWAORUR
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Lug 2023 a Lug 2024